The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: panitumumab     Quarter: 2016Q3

Total Drug/Injury Combinations: 166     Number of Pages: 9

DRUGNAME PT EventCount
panitumumab Skin hyperpigmentation 4 view events
panitumumab Abdominal pain upper 3 view events
panitumumab Conjunctivitis 3 view events
panitumumab Death 3 view events
panitumumab Detachment of retinal pigment epithelium 3 view events
PANITUMUMAB Disease progression 3 view events
panitumumab Drug eruption 3 view events
PANITUMUMAB Drug resistance 3 view events
panitumumab Embolism 3 view events
panitumumab Hypokalaemia 3 view events
PANITUMUMAB Metastases to liver 3 view events
PANITUMUMAB Metastases to lymph nodes 3 view events
PANITUMUMAB Nephrotic syndrome 3 view events
PANITUMUMAB Portal hypertension 3 view events
PANITUMUMAB Rectal adenocarcinoma 3 view events
panitumumab Sepsis 3 view events
panitumumab Tumour associated fever 3 view events
PANITUMUMAB Venoocclusive liver disease 3 view events
panitumumab Blood creatine phosphokinase increased 2 view events
panitumumab Blood creatinine increased 2 view events

Total Drug/Injury Combinations: 166     Number of Pages: 9

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)